arBtrage CAPITALIZING MARKETS checking… Sign in

Skye Bioscience, Inc.

SKYE Health Care Biotechnology: Pharmaceutical Preparations
$0.73
▼ -5.4% Today
as of Jun 7, 07:27 ET
Last 30 days -21.18% Apr 28 → Jun 05
$0.70 $0.76 $0.82 $0.88 $0.95 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.76
High
$0.77
Low
$0.71
Volume
$169,738
Avg Vol
$655,216
Mkt Cap
$30M
P/E (TTM)
Beta
52w High
$5.75
52w Low
$0.57
Div Yield
Shares Out
$35M

Overview

52-week range
$0.57
$5.75
3% of range
Avg surprise (last 2)
-0.3%
Avg reaction (last 2)
+0.2%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.17$-2.40$-1.64$-0.87$-0.10 Actual $-0.80Actual $-3.17Actual $-0.18Actual $-0.20Actual $-0.10Actual $-0.28Est $-0.31Actual $-0.44Actual $-0.32Actual $-0.32Est $-0.29 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-18M$-14M$-11M$-7M$-4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.32 $-0.29 -10.3% -14.3% +2.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.32 financials
Mon Jun 30, 2025Jun 2025 $-0.44 financials
Thu May 8, 2025Mar/2025 $-0.28 $-0.31 +9.7% -1.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.10 financials
Sun Jun 30, 2024Jun 2024 $-0.20 financials
Sun Mar 31, 2024Mar 2024 $-0.18 financials
Sat Sep 30, 2023Sep 2023 $-3.17 financials
Fri Jun 30, 2023Jun 2023 $-0.80 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-13M$-13M$-18M$-12M$-5M$-8M
Net income$-13M$-13M$-18M$-11M$-4M$-8M
EPS (diluted)$-0.32$-0.32$-0.44$-0.28$-0.10$-0.20

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$8M$6M$18M$24M$46M$68M$67M$74M
Inventory
Total current assets$19M$27M$40M$51M$63M$71M$80M$87M
Total assets$19M$28M$41M$52M$65M$73M$82M$87M
Long-term debt
Total liabilities$10M$8M$8M$8M$6M$5M$6M$14M
Total equity$9M$20M$33M$44M$59M$68M$76M$73M

Implied volatility — last 90 days

No IV snapshots yet for SKYE.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers